Annual Accounts Receivable
$865.00 K
+$865.00 K+100.00%
December 31, 2022
Summary
- As of February 11, 2025, MRTX annual accounts receivable is $865.00 thousand, with the most recent change of +$865.00 thousand (+100.00%) on December 31, 2022.
Performance
MRTX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
$14.65 M
+$4.13 M+39.23%
September 30, 2023
Summary
- As of February 11, 2025, MRTX quarterly accounts receivable is $14.65 million, with the most recent change of +$4.13 million (+39.23%) on September 30, 2023.
Performance
MRTX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
MRTX Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
MRTX Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | at high | -100.0% |
| 5 y | 5-year | at high | -100.0% | at high | -100.0% |
| alltime | all time | -79.6% | -100.0% | at high | -100.0% |
Mirati Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $14.65 M(+39.2%) |
| Jun 2023 | - | $10.52 M(+69.0%) |
| Mar 2023 | - | $6.23 M(+619.9%) |
| Dec 2022 | $865.00 K(>+9900.0%) | $865.00 K(>+9900.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2012 | - | $194.10 K(+339.1%) |
| Jun 2012 | - | $44.20 K(-77.1%) |
| Mar 2012 | - | $193.40 K(+10.3%) |
| Sep 2011 | - | $175.40 K(-72.1%) |
| Jun 2011 | - | $629.80 K(+7.8%) |
| Mar 2011 | - | $584.40 K(-19.5%) |
| Dec 2010 | $725.90 K(-2.2%) | $725.90 K(+77.5%) |
| Sep 2010 | - | $409.00 K(+31.1%) |
| Mar 2010 | - | $311.90 K(-58.0%) |
| Dec 2009 | $742.00 K(-79.8%) | $742.00 K(-65.2%) |
| Sep 2009 | - | $2.13 M(+162.7%) |
| Jun 2009 | - | $810.50 K(-42.1%) |
| Mar 2009 | - | $1.40 M(-61.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2008 | $3.68 M(-13.1%) | $3.68 M(+1.5%) |
| Sep 2008 | - | $3.63 M(-15.8%) |
| Jun 2008 | - | $4.30 M(-27.2%) |
| Mar 2008 | - | $5.91 M(+39.5%) |
| Dec 2007 | $4.24 M(+97.2%) | $4.24 M(+34.4%) |
| Sep 2007 | - | $3.15 M(+1.9%) |
| Jun 2007 | - | $3.09 M(+33.1%) |
| Mar 2007 | - | $2.32 M(+8.2%) |
| Dec 2006 | $2.15 M(+355.8%) | $2.15 M(-28.9%) |
| Sep 2006 | - | $3.02 M(+106.0%) |
| Jun 2006 | - | $1.47 M(+133.2%) |
| Mar 2006 | - | $629.00 K(+33.4%) |
| Dec 2005 | $471.50 K(+45.6%) | $471.50 K(-10.4%) |
| Sep 2005 | - | $526.10 K(+57.7%) |
| Jun 2005 | - | $333.70 K(+0.8%) |
| Mar 2005 | - | $331.00 K |
| Dec 2004 | $323.90 K(-35.7%) | - |
| Dec 2003 | $503.40 K | - |
FAQ
- What is Mirati Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Mirati Therapeutics?
- What is Mirati Therapeutics annual accounts receivable year-on-year change?
- What is Mirati Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Mirati Therapeutics?
What is Mirati Therapeutics annual accounts receivable?
The current annual accounts receivable of MRTX is $865.00 K
What is the all time high annual accounts receivable for Mirati Therapeutics?
Mirati Therapeutics all-time high annual accounts receivable is $4.24 M
What is Mirati Therapeutics annual accounts receivable year-on-year change?
Over the past year, MRTX annual accounts receivable has changed by +$865.00 K (+100.00%)
What is Mirati Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of MRTX is $14.65 M
What is the all time high quarterly accounts receivable for Mirati Therapeutics?
Mirati Therapeutics all-time high quarterly accounts receivable is $14.65 M